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Background: To examine whether lack of measurement invariance (MI) influences mean comparisons among different
disease groups, this paper provides (1) a systematic review of MI in generic constructs across chronic conditions and
(2) an empirical analysis of MI in the Health Education Impact Questionnaire (heiQ™).
Methods: (1) We searched for studies of MI among different chronic conditions in online databases. (2) Multigroup
confirmatory factor analyses were used to study MI among five chronic conditions (orthopedic condition, rheumatism,
asthma, COPD, cancer) in the heiQ™ with N = 1404 rehabilitation inpatients. Impact on latent and composite mean
differences was examined.
Results: (1) A total of 30 relevant studies suggested that about one in three items lacked MI. However, only four
studies examined impact on latent mean differences. Scale means were only affected in one of these three studies. (2)
Across the eight heiQ™ scales, seven scales had items with lack of MI in at least one disease group. However, in only
two heiQ™ scales were some latent or composite mean differences affected.
Conclusions: Lack of MI among disease groups is common and may have a relevant influence on mean comparisons
when using generic instruments. Therefore, when comparing disease groups, tests of MI should be implemented. More
studies of MI and according impact on mean differences in generic questionnaires are needed.
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Generic questionnaires are based on the idea that import-
ant aspects of patients can be described across different
chronic conditions. One such instrument, the Health Edu-
cation Impact Questionnaire (heiQ™), aims to measure
proximal outcomes of self-management programs across
disease groups on eight disparate constructs, ranging from
emotional distress to navigating the healthcare system.
Ideally, the measurement properties of generic tools
should be stable across disease-related characteristics, a
property known as measurement invariance (MI) [1].* Correspondence: m.schuler@uni-wuerzburg.de
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unless otherwise stated.MI is often studied among gender, age or ethnic groups
[2,3], but only little is known about MI across different
chronic conditions. This paper helps to close this gap in
the literature. The main research questions of this paper
are, whether non-invariant items in generic questionnaires
across different chronic conditions are a common finding
and whether non-invariant items influence the validity of
substantial statistical analyses with these questionnaires.
First, the concept of MI and some important aspects of
investigating MI are described. Second, a systematic review
of studies that examined MI across different chronic
conditions is presented. Third, the paper contains an
empirical analysis of MI of the German version of the
heiQ™. Results from the systematic review facilitate the in-
terpretation of the results of the heiQ™ MI analyses.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Schuler et al. Health and Quality of Life Outcomes 2014, 12:56 Page 2 of 12
http://www.hqlo.com/content/12/1/56Measurement invariance
MI is the property of a measure being influenced sys-
tematically only by the construct that is intended to be
measured. That is, no other characteristic of the persons
being measured (for example gender or disease group) or
the assessment context should have a systematic influence
on the measurement results [4]. Therefore, persons with
the same level in the construct of interest are expected
to have the same numerical values in the measure. If
MI does not hold between two or more groups in a
measure, estimates of mean differences between these
groups [5], correlations with other constructs [3] or
selection decisions based on cut-off values [6] may be
biased. It may even be questionable whether the instru-
ment measures the same construct among comparison
groups [5]. Therefore, MI is regarded as a prerequisite
for group comparisons [1,7].
In the literature, a range of different concepts has been
assigned to MI, for example “item bias” or “differential item
functioning” (DIF) [4,7,8]. Although these concepts differ in
some nuances from MI [4,5], they are used interchangeably
for the purposes of this article. Furthermore, different
statistical test procedures were developed to examine
MI, some of which are based on observable variables,
while others are based on latent variable models such
as item response theory (IRT) or the common factor
model [8,9]. Most of them follow the “…’matching
principle’: systematic group differences in scores on a
scale or item are considered as evidence of measurement
bias only if group differences in scores remain among
individuals who are all matched on the construct or latent
variable being measured by the scale or item” ([9], p.
S171). When using latent variable models, MI refers to
invariant model parameters, e.g. factor loadings or item
difficulties [7]. Unfortunately, different statistical methods
can lead to different results; a “… true criterion …[to detect
violations of MI did not]… stand up” ([10], p. S177).
However, three aspects should be taken into account
when studying MI: type of parameter [11], magnitude
and impact [12].
Type of parameter refers to those parameters that can
show DIF [8]. For example, multigroup confirmatory factor
analysis (CFA) allows separating and testing different levels
of MI, defined by the kind of model parameters that are
restricted to be invariant across groups. To establish
configural invariance, merely the number of latent variables
and assignments of indicators on these latent variables
have to be the same in all groups. Metric invariance is
defined by invariant factor loadings, while scalar invariance
is defined by metric invariance plus invariant intercepts.
Finally, strict invariance is defined by additionally invariant
residual (co-)variances [1,11,13]. If one or more parameters
were non-invariant, partial invariance models can be
tested, in which only some parameters on each level arerestricted to be invariant [14]. At least (partial) scalar
invariance has to be established to compare means of
latent variables, while (at least partial) strict invariance
is needed for mean comparisons in manifest variables
to be permissible, e.g. composite scores [15-17]. Notably,
in IRT-models, item discrimination parameters and item
difficulty parameters can be viewed as counterparts of
factor loadings and intercepts in common factor models,
respectively [7,18]. DIF in item difficulty parameters is
sometimes labeled “uniform” bias, while DIF in item
discrimination parameters is called “non-uniform” bias [8].
DIF in residual variances is not tested in IRT models, as
IRT models imply equal residual variances [8].
Magnitude, as defined here, refers to the size of differ-
ences in non-invariant parameters between groups, while
impact designates the influence of non-invariant param-
eters on the main research questions, for example on
mean differences in composite scores [10,19]. A researcher
may detect a non-invariant factor loading of relevant
magnitude (e.g., above 0.2 [20]) in one item of a scale.
However, it is still possible that the mean group difference
in the composite (scale) score is only marginally affected
(small “impact”). The relationship between magnitude
and impact is not quite clear. Some studies suggest that,
in general, an increase in magnitude increases impact
[3,5,21]; however, other aspects like the number of items
in a scale, direction of invariant parameters, size of other
model parameters or type of parameter may moderate
this relationship. For example, Steinmetz [5] found that
non-invariant intercepts may have a greater impact on
mean comparisons compared to non-invariant factor
loadings. Chen [3] showed that effects of multiple non-
invariant parameters on mean differences may cancel
each other out when the direction of invariant parameters
is mixed, i.e. some parameter values are higher in the
reference group and some are lower [10]. Although a
general conclusion regarding the relationship between
magnitude and impact is difficult to make, studies of meas-
urement invariance should take both features into account.
In the last 20 years, many studies have been published
to test MI in a variety of instruments in the social and
health sciences. The majority of these studies examined
MI in gender, age, language or culture [2]. Reviews of
MI studies have shown that lack of MI is a common
finding: In a review of cross-cultural MI, Chen [3] found
that 74% of reviewed studies showed non-equal factor
loadings in at least one item. According to Schmidt et al.
[2] half of the reviewed studies tested partial invariance
models, indicating that these studies found at least one
non-invariant parameter.
In the health sciences, Teresi et al. [22] reviewed studies
of MI for measures of depression, quality of life and
general health. The main question was whether MI
could be detected in the studied constructs (across any
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detect MI were appropriate. Only six of the reviewed
studies examined MI across disease groups. Half of all
studies did not examine all relevant types of MI. That is,
magnitude and impact were often studied, but with differ-
ing results: Some studies reported only minor impact,
while others reported non-ignorable impact. The review
was restricted to methods based on observable variables
and IRT models; methods based on the common factor
model were not included.
To date, no systematic review examined whether disease
group is associated with MI. However, MI across disease
groups is of special interest in health science for several
reasons: First, lack of MI might bias mean comparisons
between different conditions in a generic construct.
Second, lack of MI might also bias structural relation-
ships between different constructs in different disease
groups [3]. And finally, lack of MI might bias selection
decisions based on cut-off values [6].
In the following section, a systematic review summa-
rizes the knowledge in the scientific literature about MI
in generic instruments across different chronic conditions.
Then, an empirical investigation of MI among five different
chronic conditions using the heiQ™ is presented. After-
wards, results of both studies are discussed.
Systematic review
Research questions
The systematic review tries to find out whether chronic
condition should be regarded as a serious threat to MI in
generic instruments. To explore this, the following main
research questions were posed:
1) In general, how many items (in relation to the total
number of items in an instrument) were regarded as
non-invariant by the identified studies?
2) Do the identified non-invariant items have an impact
on mean differences or other substantial statistical
parameters?
Furthermore, the following questions should also be
answered by the review:
How many studies can be identified that examined
measurement invariance in generic instruments? Which
constructs were examined, which chronic conditions were
compared and which statistical methods used? What are
the common explanations for lack of MI and what was
recommend as the best ways to deal with it? Do some
aspects of the studies (e.g. examined construct, number
of comparison groups) correlate with the number of
DIF-Items?
In contrast to other reviews [2,3,22,23], this review was
not restricted to special statistical methods, for example
CFA, or to a special time period.Methods
Studies were identified by searching electronic databases
(Medline via both Pubmed and Ovid, PsycInfo) and by
checking reference lists in identified studies and reviews
[2,3,22,23]. Electronic search was performed on 29 August,
2012. As it was expected that results would contain many
studies from areas other than health sciences (for example
organizational research), results were filtered accordingly.
Search and filter terms as well as inclusion and exclusion
criteria are shown in Table 1.
First, titles and abstracts were screened by one reviewer
(MS). Then, full-text articles of all potentially relevant
papers were retrieved. Two independent reviewers (MS;
GM) determined eligibility of the studies.
Number of DIF-Items in relation to the whole number
of items per questionnaire was determined (0-100%).
Kendall’s τ correlation coefficients were computed between
number of DIF-Items and examined construct, number of
comparison groups, number of persons in the study, mean
number of persons per comparison group.
Results
Study selection
The search of electronic databases retrieved 4,017 refer-
ences. After filtering, 2,014 studies remained and were
evaluated on the basis of title and abstract. 91 potentially
relevant references were identified. After examination of
full-texts, a total of 30 studies were included. Interrater-
reliability in the second step was moderate (Yules Y = 0.70)
but all disagreements could be resolved by discussion.
All relevant data of the studies are presented in Additional
file 1: Table S1, online-supplement.
Constructs and instruments
A variety of constructs were examined by the reviewed
studies: physical functioning [24-32], depression [33-36],
illness-related distress [37], somatization [33], mental
health [31], pain [38], manual ability [39], daily activities
[40-42], mobility and self-care [43], quality of life [44],
health status [45], breathless severity [46], kinesiophobia
[47], dementia [48], patients opinion about their doctor
[49], caregiver reactions [50], stigmatization [51], physicians
empathy [52] and satisfaction [53].
Three instruments or scales (FIM, HAQ-DI, SF-36 Phys-
ical Functioning scale) were examined in more than
one study. 23 of the examined measures were validated
questionnaires or scales; six studies report the development
of a questionnaire and two studies examined an item bank.
One study examined two measures.
Number of patients and disease groups
In total, 34,608 patients were examined (M = 1,154,
Md = 538). Most studies compared two (n = 13) or three
(n = 11) disease groups, six studies compared five or more
Table 1 Search terms, filter terms and inclusion/exclusion criteria
Search terms “Measurement invariance”, “factorial invariance”, “measurement equivalence”, “differential item functioning”, “item bias”
Filter terms Chronic*, diagn*, patient*, rehab*, cancer, arthrit*, inflam*, diab*, rheum*, orthop*, respir*, asthm*, copd, health,
quality of life, self management, self-management, empowerment, diseas*, depress*, anxiety, trauma, injury
Inclusion criteria (a) empirical study of MI among different chronic conditions
(b) generic questionnaire
(c) adults
(d) English or German language
Exclusion criteria (a) only MI between factor correlations were studied, although scales were not combined to a total score;
(b) instruments measure disease-related constructs such as disease-specific quality of life;
(c) only specific subgroups of a chronic conditions were studied (e.g., patients with right- vs. left-hemispheric lesions).
Note: *was used as search term.
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(Md = 193). Generally, many different disorders were
compared, while most studies included at least one
neurological disorder.
Statistical methods
Most studies (n = 22) used methods based on IRT, six
studies used common factor models and two studies
used other statistical methods. Four studies investigated
only metric or configural invariance. Only eight studies
examined at least scalar invariance (i.e., both uniform
and non-unifom DIF).
Number of invariant items, magnitude, impact and
recommendations
On average, 31% (Md = 27%, Min = 0%, Max = 85%) of the
items showed DIF. Excluding those studies that studied
configural or metric MI only, DIF was found in 36% of the
items. In 25 of the examined questionnaires (81%), at least
one item showed DIF. 16 studies reported indicators of
magnitude, e.g. item difficulty parameters in disease
groups. However, 15 studies reported only p-values or
no indicators of magnitude.
Of the 24 studies that identified at least one non-
invariant item, only three examined impact on latent mean
differences (none on composite mean differences). One of
them reported statistically significant and relevant impact
(d > 0.2, see below). However, 13 studies recommended
adjusting for DIF or to be “cautious” when comparing
means between or combining data across disease groups.
Five studies examined correlations between adjusted and
non-adjusted estimates. Generally, very high correlations
(≥0.99) were reported indicating that structural relation-
ships with other variables may not be affected when
ignoring DIF. None of the studies examined impact on
selection of patients according to cut-off-values.
Explanations for DIF
A total of 15 studies gave some explanations for non-
invariant items. Most of them seemed to interpret DIFas reflections of real clinical differences. For example, in
a study of Dallmeijer et al. [25], patients with stroke
showed higher item difficulty in the SF-36 item ‘lifting/
carrying groceries’ “… than patients with other multiple
sclerosis or amytrophic lateral sclerosis, which is explained
[…] by the unilateral impairment of the arms of stroke
patients” (p. 168). Besides, some authors also reported that
undetected multidimensionality [27,36,37] or misworded
items [27,41] might cause DIF and some further referred
to other studies with similar results [28,32,34,43,45].
Studies examining physical functioning in a broader sense
(e.g. including manual ability or daily activities) showed
significant higher number of DIF-items (τ = 0.45). All other
aspects of the studies showed no correlations with number
of DIF-Items (all τ < |0.08|).
Summary
MI was examined across a variety of chronic conditions in
many different constructs. DIF between disease groups
in at least one item of a scale appears to be common.
However, despite frequent recommendations to pay atten-
tion to items with DIF (or to delete them), only few
studies explicitly examined impact of DIF on latent or
composite mean differences.
Empirical investigation of MI in the heiQ™
Research question
The empirical investigation of MI in the heiQ™ was car-
ried out among five chronic conditions (orthopedic con-
ditions, rheumatism, asthma, COPD and cancer) and
gender. Multigroup CFAs were used to test different levels
of invariance. If non-invariant parameters were found,
impact on latent and composite mean differences were
examined via effect size measures.
Methods
Sample
Patients from seven rehabilitation hospitals with a range
of medical conditions (cancer, inflammatory bowel dis-
ease, orthopedic condition, respiratory disease, rheumatic
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the beginning of inpatient rehabilitation. Parts of the
patients were a subsample of patients from the study
presented in [54]. The project was approved by the ethical
review committee of Hannover Medical School (Nr. 5070).
Participation in the study was voluntary and based on
written informed consent.
The Health Education Impact Questionnaire (heiQ™)
The heiQ™ was developed in Australia and measures
proximal outcomes of self-management programs. It
contains 40 items (4-point response scale) across eight
independent scales: Positive and active engagement in life,
Health directed activities, Skill and technique acquisition,
Constructive attitudes and approaches, Self-monitoring
and insight, Health service navigation, Social integration
and support, and Emotional distress. The scales were
developed using CFA and item response theory [55]. In
the German version, the factorial structure was replicated
with only minor adjustments (i.e. freeing error covariances
between two items in five scales each) [54]. Generally,
higher values in the heiQ™ scales indicate better status,
except for Emotional distress, in which higher values
indicate higher distress. The scales show appropriate
associations with constructs like subjective health, depres-
sion or cognitive and emotional representations of an
illness [54]. The heiQ™ can be used to display the effects
of self-management programs in outpatient and commu-
nity settings [56-59] and was recently used to guide a
Cochrane Review of self-management programs [60].
Further information on the heiQ™ can be found in [55,61].
Both in Australia and in Germany, factorial validity
was examined in about 1200 rehabilitation patients with
a variety of chronic conditions, respectively. Nolte et al.
[62] examined MI over time (response-shift [63]) in the
heiQ™. Although using a sample that included different
chronic conditions, this study suggested remarkably stable
psychometric properties of the heiQ™ over time. However,
statistical models can show good fit values in heterogeneous
samples even though subsamples may have different
parameter values [64]. Therefore, the results of these
studies cannot be interpreted as evidence of MI between
chronic conditions.
Data analysis
To test different levels of MI, several multigroup CFAs
were computed. All analyses were done with Mplus Version
6.1 [65] using robust maximum likelihood estimator. MI
was examined for each scale separately. The measurement
models of the German heiQ™ were used as baseline
models to test configural invariance. To identify the
models, the procedure suggested by Yoon & Millsap [66]
was used: For testing configural invariance, the factor
loadings of one indicator item was set to 1 (the same itemin all groups) and the mean of the latent variable was fixed
to zero in all groups. All other parameters were free to
vary among groups. To test for metric invariance, the
variance of the latent variable in the reference group
was set to 1 and all factor loadings were fixed to be in-
variant between groups (the mean of the latent variable
was still fixed to zero in all groups). Scalar invariance
was tested by additionally restricting all intercepts to be
equal between groups; the mean of the latent variable
was still fixed to zero in the reference group but was
allowed to vary across all other groups. Finally, strict
invariance was tested by restricting all residual variances
(and covariances between residual terms) to be invariant
among all comparison groups.
Configural invariance was assessed by global evaluation
of model accuracy using chi2-test as well as the model fit
indices Comparative fit index (CFI) and Root mean square
error of approximation (RMSEA). For model fit to be
interpreted as at least ‘acceptable’, CFI should be close
to 0.95 or above and RMSEA close to 0.06 or below
[67]. Following Saris et al. [20], metric, scalar and strict
invariance of parameters (factor loadings, intercepts,
residual variances) were evaluated by expected param-
eter changes (EPC) and modification indices using the
software JruleMplus [68]. A modification index can be
regarded as a test statistic for a significance test (with 1
degree of freedom) for a misspecification (e.g., a fixed
factor loading) and an EPC offers an estimate of that
misspecification. Using the formulas provided by Saris
et al. [20], we tested whether a potential misspecification
exceeds a reference value δ. δ is determined by the
researcher and represents the size of a misspecification
regarded as relevant. In studies of MI, δ represents the
minimal difference in factor loadings, intercepts etc.
among comparison groups that are regarded as mean-
ingful, respectively. In other words, δs represent the
lower limits of magnitudes of non-invariant parameters
while EPCs are estimates of actual magnitudes. However,
there are no rules of thumb for choosing appropriate
critical values for equally constraints [69,70]. For example,
Steinmetz [5] found that in scales with four or six items,
differences in (unstandardized) factor loadings of 0.3 in
one or two items may have only small, but differences in
intercepts of 0.075 times the scale range may have consid-
erable impact on latent and composite mean differences.
To be on the safe side, δ was fixed on δ =0.15 for (unstan-
dardized) factor loadings and error variances and to be
0.04 times the scale range of the latent variable (δ = 0.12)
for intercepts. Furthermore, the conclusion drawn by
the analysis must take the power of the modification
index test into account, which can be computed for every
combination of modification index, EPC, δ and signifi-
cance level alpha (which was fixed at alpha = 0.05 in this
study). We followed Saris et al. [20] and regarded results
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modification indices (i.e. modification indices < 3.84), as
“inconclusive”, which means that it is not possible to
decide whether the misspecification exceeds δ or not, i.e.
whether the examined parameter is invariant or not. For
these parameters, impact on mean differences was not
examined (see below). For more details on the outlined
procedure, see [20,69,71]. Whenever DIF was found in
a parameter, the parameter was set free and partial
invariance models were tested. When more than one
parameter was found to be non-invariant, the parameter
with the highest EPC was set free and the new model was
tested. When JruleMplus still identified non-invariant
parameters, the procedure was repeated until no further
misspecification was indicated.
The impact of non-invariant parameters on latent mean
differences was tested via comparison of mean group
differences between partial measurement invariance
models (PIM) and strict invariance model (SIM). PIM
were regarded as the “true” models, while SIM (wrongly)
assumes that all parameters were invariant across all
groups. Standardized mean differences in latent variables
[72] between comparison groups were computed in
both SIM (SIDiff ) and PIM (PIDiff ). Then the term ESSI-
PI = SIDiff-PIDiff was computed. ESSI-PI represents the
size of misestimating the standardized mean difference
between two comparison groups if a SIM is chosen.
Because SIDiff and PIDiff are comparable to Cohen’s d
[72], ESSI-PII is also a standardized value. Following
Cohen [73], values for ESSI-PI above |0.2| are regarded
as a relevant impact of non-invariant parameters on
latent mean differences.
To study the impact on group differences in composite
means, we first computed standardized effect sizes (Cohen’s
d) between comparison groups in composite scales in
two ways: One (ALLDiff ) by using all items of a scale
(and thus implicitly assuming strict MI), and one by
using a reduced scale with only strictly invariant items
between two comparison groups (REDDiff ). Then the terms
ESPI-ALL = PIDiff-ALLDiff and ESPI-RED = PIDiff-REDDiff were
computed. Assuming that PIDiff represents the “true”
difference between comparison groups, ESPI-ALL and
ESPI-RED indicate misestimation of group differences by
using ALLDiff or REDDiff. Again, values for ESPI-ALL and
ESPI-RED above |0.2| are regarded as relevant. Furthermore,
by comparing ESPI-ALL and ESPI-RED, it was examined
whether deleting non-invariant items led to an improved
estimation of group differences.
Results
Sample
The sample comprised N = 1404 German rehabilitation
patients (42% women, mean age = 56.4 years (SD = 12.2))
with different chronic conditions. All patients with or-thopedic conditions (e.g. chronic back pain) (n = 180),
rheumatism (e.g. psoriatic arthritis, ankylosing spondylitis)
(n = 312), asthma (n = 225) and COPD (n = 118) as well as
n = 136 cancer patients were from the study presented
in [54]. The sample was supplemented by an additional
n = 433 cancer patients who also filled out the German
heiQ™ at the beginning of their inpatient rehabilitation.
From all cancer patients, n = 215 were diagnosed with pro-
state cancer, n = 217 with colon or rectum cancer and
n = 137 had another type of cancer. When analyzing MI
across gender, patients with prostate cancer were excluded.
Number, kind and magnitude of non-invariant parameters
Gender In two scales, one item each did not show scalar
invariance: Item 10 in Positive and active engagement in
life (EPC = 0.12) and Item 9 in Health directed activities
(EPC = 0.16). All other scales showed strict invariance
across gender.
Disease groups Table 2 shows fit indices for strict and
partial invariance models and Table 3 shows results of
invariance tests of specific parameters. One heiQ™ scale
proved to be strictly invariant between all five disease
groups (Social integration and support). Three scales
(Emotional distress, Skill and technique acquisition, Health
directed activities) showed at least scalar invariance among
four conditions. Health service navigation was strictly in-
variant between patients with orthopedic conditions
and rheumatism on the one hand and patients with
asthma, COPD, and cancer on the other. Constructive at-
titudes and approaches showed strict invariance in three
conditions (cancer, asthma, and orthopedic conditions). Ac-
tive engagement in life showed only metric invariance be-
tween all conditions, but at least scalar invariance among
rheumatism, cancer, and COPD. Self-monitoring and
insight showed metric invariance among patients with
orthopedic conditions and cancer on the one hand and
patients with asthma, COPD, and rheumatism on the
other hand. Scalar invariance could not be established
across any chronic condition group in this scale; however, a
partial invariance model could be established. A total of 14
items (35%) showed DIF in any analyzed parameter level in
at least one disease group. However, 2–3 items showed DIF
only in residual variances, which do not affect mean differ-
ences between groups. Point estimates of EPCs for factor
loadings and residual variances were only slightly above the
defined values for δ; EPCs for intercepts ranged between
0.10 and 0.34.
Because of limited power, for some parameters in each
scale it could not be concluded whether they exceed δ
or not. However, point estimates of EPCs for these
parameters were mostly low (a table with all EPCs and
modification indices as well as power estimates may be
offered on request).
Table 2 Fit-values for strict invariance models (SI) and partial invariance models (PI) among chronic conditions
Scale Model Chi2 (df) p CFI RMSEA
Positive and active engagement in life SI 212.21 (99) <0.001 0.868 0.079
PI 121.99 (68) <0.001 0.947 0.053
Health directed activites SI 85.72 (49) <0.001 0.975 0.052
PI 69.16 (47) 0.019 0.985 0.041
Skill and technique acquisition SI 62.966 (50) 0.103 0.986 0.030
PI 45.08 (47) 0.552 1.000 0.000
Constructive attitudes and approaches SI 164.04 (88) <0.001 0.940 0.063
PI 142.26 (72) <0.001 0.952 0.059
Self-monitoring and insight SI 434.91 (108) <0.001 0.696 0.104
PI 141.97 (92) <0.001 0.953 0.044
Health service Navigation SI 259.45 (76) <0.001 0.870 0.095
PI 160.20 (72) <0.001 0.941 0.066
Social integration and support SI 155.52 (76) <0.001 0.960 0.061
PI – – – –
Emotional distress SI 255.75 (108) <0.001 0.944 0.070
PI 208.14 (105) <0.001 0.961 0.051
Notes: SI: Strict invariance model; PI: Partial invariance model (non-invariant parameters see Table 4).
Table 3 Results of tests of MI across five chronic conditions, arranged by type of parameter
Scale Configural MI Metric MI Scalar MI Strict MI
Diag Item EPC Diag Item EPC Diag Item EPC
Positive and active engagement in life ✓ ✓ ortho 2 −0.24 copd 2 0.13
ortho 5 −0.18
asthma 2 −0.17
asthma 10 0.12
Health-directed activities ✓ ✓ copd 19 0.24 (✓)
Skill and technique acquisition ✓ ✓ copd 23a −0.17 ortho 30 0.19
asthma 23a −0.09
Constructive attitudes and approaches ✓ copd 36 0.16 rheuma 36 0.13 (✓)
Self-monitoring and insight ✓ ortho 11a −0.14 ortho 3 −0.10 orthob 11 −0.13
ortho 17 −0.13
asthma 3a −0.22
asthma 17a −0.20
copd 3a −0.31
cancer 11a −0.15 copd 6 0.34
copd 17a −0.21
cancer 6 −0.28
Health-service navigation ✓ ✓ ortho 33a −0.21 (✓)
rheuma 33a −0.29
Social integration and support ✓ ✓ ✓ ✓
Emotional distress ✓ ✓ cancer 12 −0.19 ortho 7 −0.16
Notes: MI: measurement invariance; numbers (“Item”) represent non-invariant heiQ™ items in the mentioned disease group (“Diag”), followed by EPC (Expected
Parameter Change) with ortho = orthopedic conditions, rheuma = rheumatism; ✓: all parameter invariant; (✓): no new DIF parameter, but parameters of items
with DIF in a former stage were set free; ainvariant parameter in subgroups (for example item 3 has the same intercept in COPD and asthma); bin item 11,
orthopedic group and cancer group show same factor loadings and intercept, but differ in residual variances.
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Gender In both scales showing one non-invariant item
each, no relevant impact on latent or composite mean
differences was found (Positive and active engagement in
life: ESSI-PI = 0.08, ESPI-ALL = 0.13, ESPI-RED = 0.06; Health
directed behavior: ESSI-PI = 0.06, ESPI-ALL = 0.09, ESPI-
RED < 0.01).
Disease groups Table 4 shows coefficients for the impact
of non-invariant items on both latent and composite mean
differences among all five conditions for the two scales
Positive and active engagement in life and Self-monitor-
ing and insight. In all other scales, no relevant impact
was found (exact values are shown in Additional file 2:
Table S2, online-supplement).
In Positive and active engagement in life, all compari-
sons among orthopedic patients and other disease groups
in latent means were affected in a relevant manner by
non-invariant parameters (all ESSI-PI > 0.26). Accordingly,
using the composite scale with all items, differences were
also clearly misestimated (0.24 ≤ ESPI-ALL ≤ 0.32). DeletingTable 4 True standardized mean differences (PIDIFF) and impa
and composite (ESPI-ALL, ESPI-RES, upper triangle) mean differe
Disease group Ortho Rheu
Positive and active e
Ortho 0.32a
0.09
Rheu PIDiff 0.59
ESSI-PI 0.27
a
Asthma PIDiff 0.20 −0.43
ESSI-PI 0.28
a −0.02
COPD PIDiff 0.47 −0.13
ESSI-PI 0.27
a −0.13
Cancer PIDiff −0.03 −0.64
ESSI-PI 0.28
a > − 0.01
Self-monitoring
Ortho 0.11
0.02
Rheu PIDiff 0.24
ESSI-PI 0.08
Asthma PIDiff −0.34 −0.56
ESSI-PI −0.05 −0.13
COPD PIDiff −0.16 −0.38
ESSI-PI −0.03 −0.10
Cancer PIDiff −0.31 −0.55
ESSI-PI <0.01 −0.08
Notes: Ortho: orthopedic condition; Rheu: rheumatism; PIDiff: Estimations of latent m
differences between strict and partial invariance models; ESPI-ALL: Difference betwee
differences using all items of a scale; ESPI-RED: Difference between latent mean diffe
items with pairwise non-invariant parameters; arelevant misestimation (ES > |0.2|); bnthe non-invariant items in the composite scale reduces
this bias (0.03 ≤ ESPI-RED ≤ 0.17). Ignoring non-invariant
parameters did not have a relevant influence on any other
latent or composite comparisons in this scale (all ESSI-PI
and ESPI-ALL < |0.2|).
Despite showing a complex pattern of non-invariant
parameters, ignoring them in Self-monitoring and insight
did not lead to relevant misestimation of latent mean
differences (0.01 ≤ ESSI-PI ≤ 0.13). However, using com-
posite scales with all items of the scale led to a relevant
misestimation of mean differences in four comparisons
(orthopedic vs. asthma, rheumatism vs. asthma, rheuma-
tism vs. COPD, rheumatism vs. cancer). Again, deleting
non-invariant items in the composite scales reduces this
bias (all ESPI-RED < |0.13|).
Discussion
As far as we know, this is the first review of studies on
MI in generic constructs across disease groups and the
first review on MI not restricted to a specific statistical
technique. Studies of MI among diagnostic groups havect of non-invariant items on latent (ESSI-PI; lower triangle)
nces
Asthma COPD Cancer
ngagement in life
0.27a 0.31a 0.24a ESPI-ALL
0.17 0.06 0.03 ESPI-RED
0.08 0.02 0.10 ESPI-ALL
0.14 0.05 b ESPI-RED
0.06 0.02 ESPI-ALL
0.09 0.04 ESPI-RED
0.27 0.08 ESPI-ALL
0.01 0.12 ESPI-RED
−0.24 −0.52
0.01 > − 0.01
and insight
0.22a 0.12 0.10 ESPI-ALL
0.06 0.02 0.04 ESPI-RED
0.32a 0.22a 0.21a ESPI-ALL
0.13 0.08 0.10 ESPI-RED
0.09 0.13 ESPI-ALL
0.03 0.02 ESPI-RED
0.16 0.03 ESPI-ALL
0.03 0.02 ESPI-RED
0.04 −0.15
0.06 0.02
ean differences in partial invariance models; ESSI-PI: Difference in latent mean
n latent mean differences in partial invariance models and composite mean
rences in partial invariance models and composite mean differences using only
o item with DIF between groups.
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the reviewed studies was published before 2000. Disease
group appears to be increasingly recognized as an import-
ant factor that may influence MI in a variety of generic
constructs.
At first glance, the results of both the review and the
analyses of the heiQ™ seem to confirm the assumption
that MI is an important aspect when applying generic
instruments across disease groups. Over 80% of the
examined questionnaires showed at least one item with
non-invariant parameters; the mean proportion of non-
invariant items was 36% (excluding studies that examined
configural or factorial invariance only). Presumably, the
actual number of distortions in MI may even be higher.
First, only a few studies examined both uniform and
non-uniform bias. Second, apart from the studies in the
review, many studies did not examine MI directly, but
analyzed factor structure and other parameters of a
measure in specific conditions and compared results
descriptively with results of other studies. These studies
may underestimate lack of MI; hence, the number of items
showing DIF may even be higher. Likewise, 35% of the
heiQ™ items showed DIF in at least one disease group.
However, items showing DIF did not always have an
impact on the main research questions. It is difficult to
assess whether non-invariant items of the reviewed stud-
ies had relevant impact as only three studies [25,26,30]
examined influences on (latent) mean differences, with
only one showing a relevant impact [25]. Five studies
examined impact of items with DIF on structural parame-
ters indirectly, i.e. impact was explored via correlations
of DIF-adjusted and non-adjusted values. Finally, none of
the studies examined impact on either composite mean
differences or on accuracy of selection. In contrast, we
carried out a more detailed analysis of the heiQ™ where
we demonstrated that seven scales included items with
DIF. However, only few parameters were non-invariant
in five of these scales and none of them had a relevant
influence on latent or composite mean comparisons.
The remaining two heiQ™ scales, however, showed sev-
eral non-invariant parameters among disease groups. In-
deed, partial invariance models among disorders could
be proven but at least some group comparisons were
affected by non-invariant parameters.
Self-monitoring and insight: A complex pattern of non-
invariant factor loadings and intercepts among the five
disease groups indicating partial invariance was found
in this scale. This pattern may best be interpreted as a
reflection of clinical differences among disease groups.
For example, item 11 asks patients whether they know
how and when to take their medicine. However, use of
medication may have greater importance to patients in
some conditions (e.g. rheumatism or asthma) than inothers (e.g. chronic back pain). Another example is item 3
asking patients about their self-monitoring activities.
Asthma patients show a lower intercept (difficulty) than
both rheumatic and cancer patients in this item. Asthma
patients may well be more motivated to monitor their
health than rheumatic patients or cancer patients are,
because an immediate intervention (e.g. using an inhaler)
has a direct effect on their health status. Interestingly,
despite the complex pattern of non-invariant items, only a
small impact on latent means was detected. Still, some
composite mean comparisons were clearly affected.
Active engagement in life: Patients with orthopedic con-
ditions (i.e. chronic back pain) showed lower intercepts in
item 5 (“I try to make the most of my life”) and item 2
(“Most days I’m doing some of the things I really enjoy”),
resulting in a relevant impact on latent and composite
mean differences. A possible explanation may be that
psychosocial factors play a larger role in chronic back
pain than in other conditions; therefore, patients may pay
more attention to stress-reducing activities. However, this
explanation is highly speculative. More research is needed
to clarify these issues.
The review showed that a higher amount of non-
invariant items was found in studies that examined
physical functioning. A possible explanation might be
that people with different somatic diagnoses differ in
how strong different areas of activity are affected. A
general hypothesis would be that the more a measured
construct is influenceable by the kind of disease, the
higher is the probability that indicators of the construct
show DIF between disease groups. The high number of
items showing DIF in Self-monitoring and insight would
be in line with this hypothesis.
The results also clarified that DIF should not only be
regarded as an aspect of an item as such, but, in many
cases, as an interaction between item and disease group.
Many heiQ™ items showed DIF only in one of the five
comparison groups. Similar results were presented in
some reviewed studies. For example, many items in one
study [43] showed DIF only between two out of three
compared disease groups.
Limitations
Many statistical methods have been developed to examine
MI, but it remains unclear which method is the most
appropriate one to use. For example, the statistical
method used in the present study differs from the often
recommended CFA-procedure that tests for MI by
comparing global fit-values (for example chi2-difference
test or differences in CFI) [4,11,13,74]. The outlined
procedure in this study may be more sensitive to detect
“truly” non-invariant items, because the magnitude of the
EPC and the power of modification indices are taken into
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correctness of all other model parameters [20]. If more
than one parameter is non-invariant, EPCs and MIs may
also be misleading. Furthermore, the power for each
examined parameter varied greatly, due to different sample
sizes in disease groups or different sizes of model parame-
ters in different heiQ™ scales. This may have influenced the
presented results. More studies that compare different pro-
cedures for examining invariance are needed.
As (non-)invariance is a continuum rather than a di-
chotomous state [10], the results of all studies about MI
highly depend on the choice of adequate cut-off-values
for magnitude and impact, respectively. We used very
strict cut-off values in the present study, leading to a
high sensitivity to detect potential non-invariant items.
Choosing other cut-of-values may have reduced or in-
creased the number of DIF-items. Higher cut-off values
may also reduce the numbers of inconclusive compari-
sons. Up to now, only little guidance can be found in
the literature for selecting values for δ. Furthermore,
few studies proposed effect size measures for estimating
impact [75,76]. More empirical and simulation studies
are needed to help researchers define relevant cut-off
values for both magnitude and impact for all statistical
approaches examining MI (for another solution to these
problems using Bayes analyses, see [77]).
Furthermore, it is not known whether results of MI-
analyses between disease groups are consistent across
languages and cultural groups. Future work that simul-
taneously explores cross-cultural and disease-specific MI
issues seems warranted to generate information on the
presence and magnitude of bias in evaluating chronic
disease programs across countries.
Conclusion
Since most heiQ™ scales showed strict invariance across
gender and non-invariant items did not affect mean differ-
ence between men and women in a relevant manner, the
heiQ™ can be used to compare men and women without
any adjustments. In six scales, comparisons of mean
differences among disease groups were also not affected
by invariant items, again suggesting that no adjustments
have to be made. This study showed that the heiQ™ is a
robust tool for studies within disease groups and is likely
to be an unbiased measure in controlled studies with
balanced samples across disease groups. However, in
studies with unbalanced disease groups the Self-man-
agement and insight and Positive and active engagement
in life scales should be checked for distortions of MI.
To adjust for MI, we suggest comparing latent means
of partial invariance models instead of deleting non-
invariant items [5].
This study demonstrates that a lack of MI across disease
groups in generic instruments is common; maybe morecommon than in other socio-demographic variables like
gender. However, its clinical impact remains unclear.
Generally, routine examinations of the presence of invari-
ance seems to be warranted, particularly when testing
hypotheses around disease group differences and in set-
tings where researchers are seeking to develop generic
instruments for applications across disease groups [10].
This field will be advanced by more systematic studies
of MI across disease groups and other clinically rele-
vant variables. This entails simulation studies focusing
particularly on the relationship between magnitude and
clinical impact of DIF as well as qualitative methods to
elucidate sources of DIF.
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